Ascend Therapeutics
Focus: Ascend Therapeutics is a specialty pharmaceutical company headquartered in Herndon, VA with 1,001-5,000 employees, focused on women's health and specialty pharmaceuticals. Founded in 2023, the company operates a portfolio anchored by ESTROGEL and expanding into growth-stage products like SKYTROFA and YORVIPATH.
Profile data last refreshed 9h ago · AI intelligence enriched 2w ago
Employees
1001-5000
Open Jobs
0
About Ascend Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Ascend Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Ascend Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
14 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$1M Part DDeclining
LOE Approaching
Sole current revenue driver; approaching loss of exclusivity poses material financial cliff risk.
Help build intelligence for Ascend Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.